) that aresufﬁciently porous to allow unhindered mass transfer? 2) Howdoes the activity of the encapsulated catalysts compare totraditional supported Pd catalysts for CO oxidation andacetylene hydrogenation? 3) Do the shell structures providestability with respect to sintering at high temperatures?Nanoscale core/shell Pd@SiO

Highly active and sinter-resistant Pd-nanoparticle catalysts encapsulated in silica.

Core/shell structured ZnO/SiO2 nanoparticles: Preparation, characterization and photocatalytic property

Fine-tunable Ni@porous silica core–shell nanocatalysts: Synthesis, characterization, and catalytic properties in partial oxidation of methane to syngas

Fabrication of antibacterial monodispersed Ag–SiO2 core–shell nanoparticles with high concentration

A theranostic platform combining synergistic therapy and real-time imaging attracts enormous attention but still faces great challenges, such as tedious modifications and lack of efficient accumulation in tumor. Here, a novel type of theranostic agent, bismuth sulfide@mesoporous silica (Bi2S3@ mPS) core-shell nanoparticles (NPs), for targeted image-guided therapy of human epidermal growth factor receptor-2 (HER-2) positive breast cancer is developed. To generate such NPs, polyvinylpyrrolidone decorated rod-like Bi2S3 NPs are chemically encapsulated with a mesoporous silica (mPS) layer and loaded with an anticancer drug, doxorubicin. The resultant NPs are then chemically conjugated with trastuzumab (Tam, a monoclonal antibody targeting HER-2 overexpressed breast cancer cells) to form Tam-Bi2S3@mPS NPs. By in vitro and in vivo studies, it is demonstrated that the Tam-Bi2S3@mPS bear multiple desired features for cancer theranostics, including good biocompatibility and drug loading ability as well as precise and active tumor targeting and accumulation (with a bismuth content in tumor being ≈16 times that of nontargeted group). They can simultaneously serve both as an excellent contrast enhancement probe (due to the presence of strong X-ray-attenuating bismuth element) for computed tomography deep tissue tumor imaging and as a therapeutic agent to destruct tumors and prevent metastasis by synergistic photothermalchemo therapy.

/pdf/actively-targeted-deep-tissue-imaging-and-photothermal-chemo-1ud3o1cqu8.pdf

Actively Targeted Deep Tissue Imaging and Photothermal-Chemo Therapy of Breast Cancer by Antibody-Functionalized Drug-Loaded X-Ray-Responsive Bismuth Sulfide@Mesoporous Silica Core-Shell Nanoparticles.

Kan-Sen Chou

Papers

Fabrication and characterization of silver core and porous silica shell nanocomposite particles